A New Modular Stent Graft to Reconstruct Aortic Arch  by Wei, G. et al.
Eur J Vasc Endovasc Surg (2009) 37, 560e565A New Modular Stent Graft to Reconstruct
Aortic ArchG. Wei*, J. Xin, D. Yang, X. Liu, Y. Tai, H. Zhang, F. Liang, G. ZhangDepartment of Vascular Surgery, PLA General Hospital, 28 Fuxing Road, Beijing, PR China
Submitted 22 October 2008; accepted 24 January 2009
Available online 17 March 2009KEYWORDS
Aorta;
Vessels;
Stents;
Grafting* Corresponding author. Tel.: þ86 0
E-mail address: pla301dml@vip.sin
1078-5884/$34 Crown Copyright ª 20
doi:10.1016/j.ejvs.2009.01.017Abstract Background: Endovascular repair by stent graft has been developed as a safe and
less-invasive treatment for descending thoracic and abdominal aortic diseases. In case of
involvement of the aortic arch, the challenge in endovascular repair is to maintain blood flow
to the brain and upper extremities. Several studies have been done trying to repair this diffi-
cult part of the aorta with different stent grafts, and we have developed a new stent-graft
device for aortic arch reconstitution. We implanted the new device in canine models to test
its feasibility.
Methods and results: The new stent graft was composed of three components: parts I and II
were both bifurcated, one with long, narrow limb and the other short and wide, and part III
was a tubular component. Ten adult hybrid dogs were operated with the new stent-graft
procedure, and eight were successfully implanted with the stent grafts. The technical success
rate was 80% (8 of 10). Five dogs survived for 3 months without obvious cerebral, visceral or
limb ischaemia. Autopsies showed that the implanted stent grafts were patent and the vital
side branches of aortic arch were well preserved.
Conclusions: Our study demonstrates that it is possible to reconstruct aortic arch with the new
branched stent grafts. The advantage of this device is that it is modular, more adaptable and
surgical bypass could be possibly avoided.
Crown Copyright ª 2009 Published by Elsevier Ltd on behalf of European Society for Vascular
Surgery. All rights reserved.Endovascular aortic repair has been developed as a safe
and effective treatment modality in various diseases of the
descending thoracic aorta and abdominal aorta and has
gained popularity for treating patients with a poor10 66937355.
a.com (G. Wei).
09 Published by Elsevier Ltd on bconditioned.1,2,3,4,5,6,7,8 However, when the aortic arch is
involved, endovascular repair turns to be very difficult. The
main challenge lies in maintaining blood flow to the vital
branches of brain and upper extremities while the aortic
arch is being covered by the stent graft.
Some innovative studies have been done to reconstruct
aortic arch by endovascular methods.9,10,11,12 Inoue et al.
successfully treated a case of Stanford A dissection withehalf of European Society for Vascular Surgery. All rights reserved.
New Modular Stent-graft to Reconstruct Aortic Arch 561a stent graft bearing side branches to the innominate, left
carotid and left subclavian arteries.9 This was the first time
a reconstruction of the aortic arch and its side branches
was performed entirely by endovascular method. However,
the Inoue device was custom-made, individually designed
and the implantation procedures were rather complicated.
Chuter et al. developed another method10 where they
applied a bifurcated stent graft to repair aortic arch by
maintaining blood flow to the innominate artery through
one branch, and blood flow to the left carotid and subcla-
vian arteries were supplied through extra-anatomical
surgical bypass grafts. This method made stent-graft
implantation procedure less complicated compared to that
with the Inoue device, but the disadvantage was that
surgical bypass was indispensable and therefore the cor-
responding operational risks increased.
Based on the Chuter device, we developed a newmodular
branched stent graft such that the whole procedure could be
performed endovascularly, thus avoiding surgical bypass. In
order to test the feasibility of this new device, we performed
the implantation procedure in canine models.
Methods
Design and manufacture of the stent-graft system
The stent graft was manufactured from self-expanding
Gianturco stainless steel Z stent covered with expanded
polytetrafluoroethylene (ePTFE) grafts (Xianjian, China).
The graft material was attached to the stent with 5/
0 polypropylene sutures (Ethicon). Each stent graft was
composed of three modular parts: parts I, II and III. Both
parts I and II were bifurcated components with two limbs,
one was a long narrow limb and the other was short and
wide. Part III was a tubular component (Fig. 1). All three
parts were inserted into an 18-Fr Teflon delivery sheath and
deployed by withdrawing the outer sheath. It was plannedFigure 1 Modular parts of the new stent graft. From left to
right are parts I, II and III, respectively. Upper-right corner is
the assembled stent graft in vitro.that, when the stent graft was deployed in vivo, both the
innominate and left carotid arteries were to be preserved
and the left subclavian artery was to be occluded in
advance (Fig. 2A). This design is based on the well-
accepted knowledge that the left subclavian artery can be
covered in most people directly.13,14,15,16,17
Aortography shows that a normal hybrid dog has two side
branches on theaortic arch.Onebranch gives rise to bilateral
carotid arteries and right subclavian artery, and the other
branch is the left subclavian artery. Although the structure of
canine aortic arch is a little different from that of humans, it
is still an ideal substitute model for our new stent-graft
deployment due to its two-branched configuration (Fig. 2B).
Aortography and target vessels measurement
To manufacture the stent grafts suitable for a canine
model, we first performed aortography on hybrid dogs and
data of the target vessels were recorded. The procedure of
aortography is as follows.
A total of 10 adult, male, hybrid dogs (weighing 23.5e
25.5 kg) were used in this study. All of the animals were
cared for in accordance with the guidelines approved by
the PLA General Hospital Animal Experiment and Care
Committee. The dogs were sedated with an intramuscular
injection of ketamine hydrochloride (10 mg kg1 body
weight) and atropine sulphate (0.08 mg kg1). After seda-
tion, the sheath catheter was inserted in the right femoral
artery of the dog using the Seldinger method. An intrave-
nous injection of heparin (50 UI kg1) was administered to
each dog and a total of 12 ml of contrast agent
(Ultravist300; Schering) was injected at a rate of 6 ml s1
using a 5-Fr marked pigtail catheter through the sheath.
The length and diameter of target vessels were measured,
and the data were recorded. The outer diameters of the
stent grafts were set to be 1020% larger than those of the
proximal and distal landing zones of target vessels.Figure 2 Scheme of aortic arch aneurysm repair with a new
device in human being and canine model. (A) Endovascular
repair in human being. Innominate artery and left carotid
artery were preserved, and left subclavian artery was inten-
tionally occluded. (B) Endovascular repair in canine model.
There are two side branches on canine aortic arch. One branch
is the innominate artery that gives rise to bilateral carotid and
right subclavian arteries, and the other is the left subclavian
artery.
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model
The dogs were sedated with an intramuscular injection of
ketamine hydrochloride (10 mg kg1 body weight) and
atropine sulphate (0.08 mg kg1), and followed by endo-
tracheal intubation and mechanical ventilation with
2 l min1 of oxygen after induction with intravenous sodium
thiopental (25 mg kg1). Anaesthesia was followed by
intravenous pentobarbital and pancuronium administra-
tions. Intravenous hydration with normal saline was main-
tained during the surgery, and antibiotics were given at the
start and continued for 3 days. Heparin was given repeat-
edly throughout the operation to maintain activated clot-
ting time of at least 300 s.
After skin sterilisation, both the bilateral subclavian and
common femoral arteries were exposed. A short sheath and
a 5-Fr marked pigtail catheter were introduced from left
common femoral artery into the ascending aorta for real-
time angiography. Right subclavian arterywas punctured and
a short sheath was introduced. A stiff guidewire (Lunder-
quist; Cook Inc., Indianapolis, IN, USA) was inserted from the
right subclavian access into the ascending aorta, and
the delivery system containing part I was introduced. The
delivery system was advanced into the ascending aorta and
positioned to avoid covering the orifice of the coronary
arteries. The central pusher maintained the position of the
device,while theouter sheathwaswithdrawn, thus releasing
the stent graft part I with the short limb left inside the
ascending aorta and the long limb left inside the innominate
artery. Then the left subclavian artery was punctured, and
a small sheath was inserted for access. A guidewire was
advanced, together with a selective catheter, and the wire
was accommodated into the short limb of part I. Then the
delivery systemcontaining part II was advanced over the stiff
wire through the left subclavian artery access. The main
body of part II was overlappedwith the short limb of part I for
at least 15 mm in length. Part II was positioned and released,
and the long limb left was inside the left subclavian artery.
The right femoral artery was punctured, and the short aortic
limb of part II was cannulated with the same way mentioned
above.Thedelivery systemcontaining the tubular part IIIwas
advanced into the short limb of part II and released, with the
distal part extending into the descending thoracic aorta. The
overlapping length of parts II and III was also at least 15 mm.
Each landing and overlapping area was expanded with
a balloon to prevent endoleak. The whole implantation
procedure was completed in this manner (Fig. 3AeD).
Results
Technical results
Ten adult hybrid dogs were operated with the endovascular
procedure; of these, two died during the operation and
eight were successfully implanted with the new stent
grafts. One dog died of acute myocardial infarction because
the coronary arteries were covered by part I accidentally.
The other failure occurred due to rupture of the right
subclavian artery during part I delivery, and the animal died
of subsequent hypovolaemic shock. The technical successrate was 80% (8 of 10), the average operation time was
320 min (270e400 min), and the average blood loss was
175 ml (30e350 ml) for each procedure.
Blood pressure difference across the new device
After stent-graft deployment, all the blood supply to the
lower extremity and visceral arteries would pass through
the short, wide limb of part II, which was the narrowest
part of the whole stent-graft system with a diameter of
15 mm. To assess whether blood supply to these areas was
sufficient, we measured the blood pressure difference
between the ascending and descending aortas after the
stent-graft deployment, which was also the blood pressure
difference across the whole device system. The blood
pressure was measured by connecting the angiographic
pigtail catheter to a sphygmomanometer. Data are recor-
ded as in Table 1.
Short-term outcome
Of the eight animals that were successfully implanted with
stent grafts, three died within 24 h after the operation, and
the remainingfivedogs survived for 3monthswithout obvious
cerebral or limb ischaemia. All the three deaths came at an
early stage in the research because of the operators’ lack of
experience, especially since the cannulation of short limbs
were time consuming and led to excessive loss of blood. In
addition, after the operations, the three dogs, kept in
hypovolaemic shock, did not recover from anaesthesia and
the autopsies later showed that all the deployed stent grafts
were patent. Four out of five dogs died early in the research,
three were as mentioned above and the other failure was
from a ruptured right subclavian artery due to a violent
pullback of part I. With experience, we could control the
operation time, avoid excessive blood loss and the latter five
experiments worked well, except for one animal that died of
unintentionally occluded coronary arteries. Computer
tomography scan was performed on one surviving dog 2
weeks later, and it showed that the implanted stent graftwas
patent and no obvious endoleak or stent-graft migration was
observed, and the vital side branches were well preserved
(Fig. 3E). Threemonths later, thefiveanimalswere sacrificed
for autopsy, revealing that the implanted stent grafts and all
the vital branch vessels were patently conserved.
Discussion
Several studies have been done for endovascular recon-
struction of the aortic arch. Chuter et al. method main-
tained blood flow to the innominate artery through
a branch of the bifurcated stent graft, and blood flow to the
left carotid and subclavian arteries were supplied by extra-
anatomical surgical bypass grafts.10 Thus, median sternot-
omy is avoided and surgical risks are decreased, but the
procedure still needs surgical bypass. Inoue et al. treated
a case of aorta dissection involving aortic arch with
a custom-made stent graft.9 This was the first time an
entirely endovascular reconstruction of the aortic arch and
its vital branches was undertaken. However, the Inoue
device is custom-made and must be individually designed.
Figure 3 (A) Deployment of part I, (B) deployment of part II, (C) deployment of part III, (D) aortography after the whole
procedure was completed and (E) CT scan 2 weeks after the stent-graft implantation.
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enough to cater to the complex configuration and variation
of aortic arch. Based on the Chuter device, we developed
a new stent-graft device for aortic arch diseases, which was
composed of three parts: parts I, II and III. Parts I and II
were both bifurcated, one with a long, narrow limb
supplying blood to the brain, and the other short and wide.
Part III was a tubular component and could extend into the
descending thoracic aorta. Similar to the Inoue device, our
product also can be used to treat aortic arch diseases
endovascularly, and surgical bypass could be avoided.
However, the difference is that our device was modular and
not custom-made, and the size of each modular part waschosen according to angiographic measurement before the
operation. In addition, the key techniques and the tools
needed in our procedure, such as wires and catheters, were
basically the same as that was widely used in the abdominal
aorta aneurysm repair. No further special training on the
implantation procedure was necessary.
However, several issues concerning this new device need
to be elucidated.
Blood supply to the brain and upper extremities
It has been well accepted that left subclavian arteries of
most people can be directly occluded as long as the right
Table 1 Systolic blood pressure difference between the
ascending and descending aortas after stent-graft implan-
tation in a canine model (unit: mmHg)
Number
of dogs
SBP (ascending/
descending aorta)
Blood pressure
difference
1 e e
2 130/125 5
3 108/105 3
4 95/90 5
5 110/105 5
6 115/110 5
7 e e
8 106/100 6
9 135/130 5
10 125/119 6
Average 115.5/110.5 5
SBP (ascending/descending aorta): systolic blood pressure of
ascending aorta and descending aorta, respectively.
Animal Nos. 1 and 7 did not survive the procedure and no data
were recorded.
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mal.9e17 Our experience in endovascular treatment of
Standford type B dissection has also proved this.18 This
knowledge laid the theoretical basis for our device, which
preserved the blood flow to the innominate artery and left
carotid artery, yet without a side branch to left subclavian
artery.
Another issue concerns blood supply to the brain during
stent-graft deployment. In the canine model, there are two
branches arising directly from aortic arch, left subclavian
artery and innominate artery. Aortography showed that the
diameter of canine innominate artery was about 8 mm, and
the outer diameter of the part I delivery system was 18-Fr
(6 mm). Therefore, when the main body of part I was
deployed through the innominate artery, the blood supply
to the brain and upper extremity was not totally shut down
and was still supplied by the remnant innominate artery
cavity and left subclavian artery. However, this procedure
should be concluded as early as possible to reduce the
possible brain ischaemia time. When part I was deployed in
humans, blood supply to the brain could be supported by
left subclavian artery, left carotid artery and the remnant
cavity of innominate artery. Therefore, the chances of
brain ischaemia should be even lesser, as proved by the
Chuter study10 and our own clinical experience.19Blood supply of visceral organs and lower
extremities
On completion of the procedure, all the blood supply to the
lower extremities and visceral organs would flow through
the trunk of the device. The diameter of the narrowest part
of the device, which is the short wide limb of part II, is
15 mm. The average diameter of the descending aorta in
the canine model in our experiment group was 29 mm. In
order to evaluate whether the visceral organs and lower
limbs received sufficient blood supply, we measured the
blood pressure difference between the ascending aorta andthe descending aorta, which was the blood pressure
difference across the whole stent-graft system. As a result,
the average blood pressure difference was 5 mmHg, and
this was not supposed to cause any serious ischaemia of
distal organs.
In conclusion, our study demonstrates that it is feasible
to reconstruct aortic arch with the new, modular, branched
stent grafts. The advantage of this new device is that
surgical bypass could be avoided and, compared with
previous literature, our device was modular, seemed to be
more adaptable and the implantation procedure be less
complicated. More research and further improvements on
this device are needed before its final clinical application.
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